TheenvProtein of an Infectious Noncytopathic HIV-2 Is Deficient in Syncytium Formation
- 1 June 1990
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 6 (6) , 707-720
- https://doi.org/10.1089/aid.1990.6.707
Abstract
A recent isolate of human immunodeficiency virus type 2 (HIV-2) designated HIV-2ST is deficient in its ability to cause the typical cytopathic effects of HIV infection. The pathogenic potential of HIV-2 in inducing human disease may be less than that of HIV-1, and it is of particular interest to establish the basis for the reduced cytopathogenicity of this isolate in vitro. Utilizing recombinant vaccinia viruses (rVV) carrying the envelope genes (env) of HIV-2ST or those of fully cytopathic HIV-1 or HIV-2 isolates, we have investigated envelope glycoprotein expression, processing, transport, and biological function. Radioimmunoprecipitation and polyacrylamide gel electrophoresis (RIP-PAGE) of rVV-infected cell lysates indicated that the proteins expressed by each recombinant were synthesized, processed, and recognized by specific antisera. Immunofluorescence studies showed that the recombinant env gene products of HIV-2ST and HIV-2ROD reach the cell surface and are retained there in similar amounts. Whereas cells expressing the HIV-1 or HIV-2ROD env gene products were found to undergo fusion with uninfected CD4+ cells, no syncytium formation was observed with three CD4+ cell lines exposed to the cells expressing the envelope glycoproteins of HIV-2ST on their surfaces; one CD4+ lymphoid cell line (SupT1) exhibited few very small syncytia in the presence of recombinant HIV-2ST envelope glycoproteins. The failure of the HIV-2ST envelope glycoprotein to induce cell fusion was not the result of an inhibition by cell-associated CD4, since fusion was also not observed when rVVST-infected CD4- cells were cocultured with CD4+ cells. Thus, the HIV-2ST envelope protein itself is defective in its ability to induce cell fusion. Furthermore, the expression, processing, transport, and surface stability of env products of HIV-2ST are unlikely to be responsible for its attenuation, suggesting that the molecular interactions between its env products and target cell membranes are significantly altered.This publication has 51 references indexed in Scilit:
- HIV-1, HIV-2, and HTLV-I Infection in High-Risk Groups in BrazilNew England Journal of Medicine, 1989
- Isolation and Characterization of a Novel Protein (X-ORF Product) from SIV and HIV-2Science, 1988
- The Human Immunodeficiency Virus Type 2 (HIV-2) Contains a Novel Gene Encoding a 16 kD Protein Associated with Mature VirionsAIDS Research and Human Retroviruses, 1988
- Relation of HTLV-4 to simian and human immunodeficiency-associated virusesNature, 1987
- Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virusCell, 1987
- pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membraneCell, 1987
- Human Immunodeficiency Virus Type 2 Infection Associated with AIDS in West AfricaNew England Journal of Medicine, 1987
- The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brainCell, 1986
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970